Compare ASND & PAYP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASND | PAYP |
|---|---|---|
| Founded | 2006 | 2018 |
| Country | Denmark | Japan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.5B | 12.9B |
| IPO Year | 2014 | 2026 |
| Metric | ASND | PAYP |
|---|---|---|
| Price | $210.87 | $15.07 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 9 |
| Target Price | ★ $281.50 | $25.54 |
| AVG Volume (30 Days) | 532.4K | ★ 886.7K |
| Earning Date | 05-12-2026 | 08-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $96.35 | N/A |
| Revenue Next Year | $44.91 | $20.92 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $161.09 | $15.69 |
| 52 Week High | $250.74 | $24.89 |
| Indicator | ASND | PAYP |
|---|---|---|
| Relative Strength Index (RSI) | 33.76 | 27.23 |
| Support Level | $190.56 | N/A |
| Resistance Level | $218.88 | $19.95 |
| Average True Range (ATR) | 8.26 | 0.78 |
| MACD | -3.26 | -0.42 |
| Stochastic Oscillator | 0.19 | 0.60 |
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
PayPay is a fintech company jointly owned by Softbank and LY. It was founded in 2018, following the success of Alipay and WeChat Pay in China, and was the pioneering code payment app in Japan. Over the past seven years, it has amassed more than 70 million users and is the market leader in code payments.